BGAI
Bruce G. Allen Investments Portfolio holdings
AUM
$132M
This Quarter Return
-3.43%
1 Year Return
+15.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$123M
AUM Growth
+$123M
(-4.3%)
Cap. Flow
+$10.4M
Cap. Flow
% of AUM
8.45%
Top 10 Holdings %
Top 10 Hldgs %
54.48%
Holding
1,155
New
39
Increased
291
Reduced
298
Closed
66
Top Buys
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
$5.5M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
$5.24M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
$865K |
| 4 |
Vanguard Value ETF
VTV
|
$349K |
| 5 |
Vanguard Small-Cap Value ETF
VBR
|
$349K |
Top Sells
Sector Composition
| 1 | Financials | 7.51% |
| 2 | Technology | 5.65% |
| 3 | Healthcare | 4.66% |
| 4 | Industrials | 4.1% |
| 5 | Consumer Staples | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Merck
MRK
$210B
| $315K | 0.26% |
3,163
+27
| +0.9% | +$2.69K |
|
52
iShares Russell Mid-Cap ETF
IWR
$44.4B
| $307K | 0.25% |
3,475
+12
| +0.3% | +$1.06K |
|
53
Cisco
CSCO
$274B
| $298K | 0.24% |
5,042
-45
| -0.9% | -$2.66K |
|
54
Sanofi
SNY
$121B
| $296K | 0.24% |
6,146
-84
| -1% | -$4.05K |
|
55
Blackrock
BLK
$175B
| $293K | 0.24% |
286
-6
| -2% | -$6.15K |
|
56
Capital Group Dividend Value ETF
CGDV
$21.2B
| $281K | 0.23% |
7,957
+869
| +12% | +$30.6K |
|
57
Vanguard Dividend Appreciation ETF
VIG
$95.4B
| $279K | 0.23% |
1,425
+53
| +4% | +$10.4K |
|
58
NextEra Energy, Inc.
NEE
$148B
| $273K | 0.22% |
3,806
-4
| -0.1% | -$287 |
|
59
Abbott
ABT
$231B
| $273K | 0.22% |
2,412
-11
| -0.5% | -$1.24K |
|
60
SPDR Gold Trust
GLD
$107B
| $272K | 0.22% |
1,124
-123
| -10% | -$29.8K |
|
61
Visa
V
$683B
| $251K | 0.2% |
795
-4
| -0.5% | -$1.26K |
|
62
Novartis
NVS
$245B
| $239K | 0.19% |
2,454
-240
| -9% | -$23.4K |
|
63
Honeywell
HON
$139B
| $235K | 0.19% |
1,042
+21
| +2% | +$4.74K |
|
64
Accenture
ACN
$162B
| $229K | 0.19% |
652
+43
| +7% | +$15.1K |
|
65
Philip Morris
PM
$260B
| $222K | 0.18% |
1,848
-59
| -3% | -$7.1K |
|
66
Linde
LIN
$224B
| $217K | 0.18% |
518
-3
| -0.6% | -$1.26K |
|
67
Charles Schwab
SCHW
$174B
| $215K | 0.17% |
2,907
-103
| -3% | -$7.62K |
|
68
Morgan Stanley
MS
$240B
| $214K | 0.17% |
1,700
-46
| -3% | -$5.78K |
|
69
GSK
GSK
$79.9B
| $207K | 0.17% |
6,113
+50
| +0.8% | +$1.69K |
|
70
Bristol-Myers Squibb
BMY
$96B
| $200K | 0.16% |
3,538
+133
| +4% | +$7.52K |
|
71
Unilever
UL
$155B
| $199K | 0.16% |
3,513
-123
| -3% | -$6.97K |
|
72
Schwab International Dividend Equity ETF
SCHY
$1.3B
| $198K | 0.16% |
8,585
+3,735
| +77% | +$86.4K |
|
73
Chubb
CB
$110B
| $197K | 0.16% |
713
+142
| +25% | +$39.2K |
|
74
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $197K | 0.16% |
4,112
+2,652
| +182% | +$127K |
|
75
Walmart
WMT
$774B
| $196K | 0.16% |
2,170
-133
| -6% | -$12K |
|